CaPTC Biennial Meetings

To continue to address the growing global public health problem of prostate cancer among Black men in industrialized and developing countries, CaPTC hosts the "Biennial Science of Global Prostate Cancer Disparities in Black men conference." The goals are to:

  1. Provide opportunities for mutual learning, knowledge transfer, and collaborations among prostate cancer scientists, clinicians, survivors and advocates;
  2. Promote transdisciplinary and multidisciplinary prostate cancer research globally;
  3. Facilitate networking among individuals involved in all aspects of prostate cancer control, education, and research in Black men;
  4. Facilitate the development of a global community of practice to address common challenges in prostate cancer, including prevention, detection, diagnosis, treatment, and survivorship; and
  5. Contribute to a global impact against prostate cancer through research, training, education, and advocacy programs for low-resource countries.

In 2010, the first biennial conference on "The Science of Global Prostate Cancer Disparities in Black Men" was held in Jacksonville, Florida, August 27-29, 2010. Supported by NCI, the first conference was an overwhelming success. A total of 96 delegates and 21 patient/survivors participated. Fifteen international delegates came from Africa, the Caribbean, and United Kingdom. The overall goal of the conference was achieved as participants were able to learn from internationally renowned speakers about the latest research findings, share ideas with other conference delegates, and explore the world of transdisciplinary prostate cancer research. View the 2010 conference proceedings and abstractsExternal Web Site Policy.

The fifth biennial conference was held in Ilorin, Nigeria November 7-10, 2018.

The sixth biennial conference is divided into two parts, the first, a virtual conference was held December 6th -10th, 2020. In-person sessions are being planned for Fall 2021. More details will be added to this page as they become available.